An appropriate balance between uterine quiescence and activation during pregnancy is essential for a successful outcome. Sphingosine 1-phosphate (S1P), a bioactive lipid, increases cell survival, proliferation, and angiogenesis, all important to maintain the pregnancy. Indeed progesterone increases sphingosine kinase 1 (SPHK1) mRNA, which produces S1P. In contrast, induction of prostaglandin endoperoxide synthase 2 by S1P and stimulation of SPHK1 by estradiol and cytokines suggests a role for S1P in the termination of pregnancy. Human decidua is important for regulating the maintenance and termination of pregnancy with production of progesterone receptors, cytokines, and prostaglandins. We hypothesized that S1P is produced by and acts on the decidua to stimulate production of mediators that induce labor. Our objective was to investigate the metabolism of S1P and its receptors in human decidua during pregnancy. We found that SPHK1 protein and activity positively correlated with increasing gestational age in human decidua parietalis. This was accompanied at term by increased expression of the S1P lyase, which irreversibly degrades S1P. This implies increased S1P turnover in the decidua at term. Although the mRNA level of phosphatidic acid phosphatase type 2A and 2B (PPAP2A,B), which dephosphorylate extracellular S1P, were increased at term, PPAP2 activity did not change. Sphingosine 1-phosphate receptor 3 protein expression also increased at term, indicating increased signaling by S1P in the decidua. There were no differences in any parameter tested in decidua from women in labor compared to those who were not. This work provides the first evidence of increased S1P synthesis, degradation, and signaling in human decidua during gestation.
INTRODUCTION
The lipid sphingosine 1-phosphate (S1P) has important roles in cardiovascular disease [1, 2] , cancer [3] , and inflammation [4] because of its numerous signaling actions [5, 6] . Sphingosine 1-phosphate has differential effects on cell survival, motility, proliferation, contraction, angiogenesis, and vascular permeability, all of which are important to both maintenance and termination of pregnancy. Sphingosine 1-phosphate levels depend on the balance of its synthesis and degradation. Sphingosine 1-phosphate is produced from sphingosine by two isoforms of sphingosine kinase (SPHK), SPHK1 and SPHK2. When SPHK1 is activated by phosphorylation, it translocates to the plasma membrane [7] , and this is a key step in driving S1P signaling [8, 9] . Sphingosine 1-phosphate can be irreversibly catabolized by a specific enzyme, S1P lyase (SGPL1) [10] . Sphingosine 1-phosphate metabolism also involves dephosphorylation by two S1P phosphatases (SGPPs) inside the cell and by phosphatidic acid phosphatases (PPAP2s), also known as lipid phosphate phosphatases [11] , which act as ectoenzymes [12] . S1P stimulates both intracellular and extracellular signals [6] . Intracellular signaling involves the stimulation of Ca 2þ -transients and cell division, but the mechanisms are not well understood. Extracellular signaling involves interactions with five G protein-coupled receptors, S1PR1-5 [13] . The expression of these receptors are tissue and cell-type specific: S1PR1 is ubiquitous, whereas S1PR2 and S1PR3 are more restricted with expression primarily in gastrointestinal, vascular, and central nervous systems. S1PR4 is localized to lymphoid tissues, and S1PR5 is in nerve tissues [6] .
In animal models, SPHK expression is increased by progesterone and decreased by a progesterone receptor antagonist [14] . On the other hand, estrogen also stimulates SPHK1 activation [3] , and S1P production is increased by the cytokines, tumor necrosis factor-alpha (TNF-a), and interleukin 1-beta (IL1B) [4, [15] [16] [17] [18] , which are also associated with labor induction. Leiber et al. showed that exogenous S1P induced myometrial contraction [19] . These data suggest that S1P could both maintain and/or terminate pregnancy. However, the actual role of S1P, particularly in human pregnancy and labor, is not understood.
Decidua, which is derived by modification of the maternal endometrium during pregnancy, is important for maintaining and terminating pregnancy because of its key location between the maternal uterine myometrium and fetal membranes (chorion and amnion). Sphingosine 1-phosphate is reported to be involved in decidualization in animal models [20] . Thus, the probability of S1P signaling from human decidua during the second half of gestation is high, but changes in the expression of enzymes involved in S1P turnover and its receptor expression have not been characterized. Our overall hypothesis is that S1P is produced by and acts on the decidua at term to stimulate production of mediators that induce labor. Our specific hypothesis is that S1PR expression and SPHK expression and activity would increase only in decidua isolated from women in labor regardless of the gestational age. We further hypothesize that enzymes that metabolize S1P would decrease. The objective of this study is to characterize the expression and activity of enzymes involved in production and reversible or irreversible metabolism of S1P along with S1P receptor expression.
MATERIALS AND METHODS

Materials
Normal goat serum was obtained from Cedarlane (Burlington, ON, Canada). Antibodies were purchased as follows: rabbit S1PR1 polyclonal and rabbit S1PR3 polyclonal antibodies (Cayman, Burlington, ON, Canada); GAPDH monoclonal antibodies (mouse IgG and rabbit IgG isotypes; Sigma, St. Louis, MO); mouse cytokeratin monoclonal antibody (Vector Laboratories, Burlingame, CA); mouse vimentin monoclonal antibody (Dako Canada Inc., Mississauga, Ontario, Canada); rabbit SPHK1 polyclonal (Abcam, Cambridge, MA); rabbit SGPP1 polyclonal, rabbit SGPP2 polyclonal, rabbit S1P lyase polyclonal, rabbit LPP3 polyclonal antibodies, and S1P lyase antibody blocking peptide (Exalpha, Watertown, MA); goat anti-rabbit IgG conjugated to Alexa Fluor-488 and goat anti-mouse IgG conjugated to Alexa Fluor-594 for immunofluorescence (10mg/mL; Invitrogen, Burlington, ON, Canada); goat anti-rabbit IgG conjugated to IRDye 800 and goat anti-mouse IgG conjugated to IRDye 680 for Western immunoblotting (LI-COR, Lincoln, NE). Vectashield H:100 was obtained from Vector Laboratories; TRIzol, random primers, SuperScript II reverse transcriptase, and 4 0 , 6-diamidine-2-phenylindole dihydrochloride (DAPI) were from Invitrogen. AmpErase and 2 3 SYBER green buffer were from Applied Biosystems (Streetsville, ON, Canada). Odyssey blocking buffer was obtained from LI-COR. Prestained protein molecular weight markers were from Fermentas (Burlington, ON, Canada). [c- 32 P] ATP was from Perkin Elmer (Waltham, MA). PhosSTOP was from Roche (Nutley, NJ), and protease inhibitor cocktail was from Sigma. Preterm birth is defined as less than 37 weeks of gestation. The indications for preterm Cesarean delivery were fetal anomalies, breech presentation, and nonreassuring fetal status. The indications for term Cesarean delivery included previous Cesarean section and breech presentation without premature rupture of membranes. Pregnancies affecting fetal growth were excluded, including gestational diabetes and intrauterine growth restriction. All placentas with attached fetal membranes were collected at the Royal Alexandra Hospital in Edmonton. The chorion was peeled from the amnion, and decidua was isolated by scraping from the chorion. Contamination by chorion trophoblast cells was less than 10% in all the samples (see Supplemental Fig.  S1 ; all Supplemental Data are available online at www.biolreprod.org). All the tissues were stored at À808C until processed. All the research conducted followed the Declaration of Helsinki guidelines and were approved by the Health Research Ethics Board at the University of Alberta.
Isolation of Human Decidua
Immunofluorescence
Decidual tissues were fixed in 4% formaldehyde overnight followed by incubation in 30% sucrose overnight. The tissues were embedded in optimalcutting temperature compound, and 5-lm sections were cut using a cryostat. All the sections were stained simultaneously to ensure consistent staining. Sections were incubated with 100% methanol for 10 min, washed with PBS three times for 5 min, and blocked with 10% normal goat serum for 1 h. The sections were then incubated overnight at 48C with primary antibody (rabbit anti-S1PR1 1:50, rabbit anti-S1PR3 1:100, rabbit anti-SPHK1 1:50, mouse anticytokeratin 1:100, mouse antivimentin 1:100). After washing with PBS three times for 5 min, the sections were incubated for 1 h at room temperature with secondary antibodies with fluorescent tags (goat anti-rabbit tagged with Alexa Fluor 488 1:200; goat anti-mouse tagged with Alexa Fluor 594 1:200). Slides were washed with three 5-min washes of PBS and incubated with DAPI to stain nuclei for 15 min at room temperature. Slides were then washed again once with PBS, and 45 lL of Vectashield H:1000 was applied to each section. Coverslips were sealed to the slides and stored in the dark at 48C. Stained sections were viewed with an Olympus IX81 fluorescent microscope (Olympus, ON, Canada) using Slidebook 2D, 3D Timelapse Imaging Software (Intelligent Imaging Innovations Inc., Denver, CO). All the photomicrographs were taken using identical exposure parameters.
Real-Time PCR
Total RNA was isolated from decidual tissues using Trizol. The quality of the isolated RNA was confirmed by 1% agarose gel in 20 mM 3-(Nmorpholino)propanesulfonic acid. Total RNA (500ng) was reverse-transcribed using the SuperScript First-Strand Synthesis System according to the manufacturer's instructions. PCR was performed in a final volume of 25 ll that contained 12.5 ll of 2 3 SYBER green buffer, 10 lM of forward and reverse primers, 0.25 ll Amp Erase, and 50 ng of cDNA. The primer sequences used are shown in Supplemental Table S1 . The cycling conditions were as follows: 508C for 2 min, initial denaturation at 958C for 10 min, followed by 40 cycles of 958C for 15 sec, and adequate annealing temperature for 1 min. Melt curve analysis was performed as follows: 958C for 1 min, 558C for 1 min, followed by increasing 0.58C temperature every 12 sec from 558C to 958C. The results were normalized to those for GAPDH.
Western Immunoblotting
Tissues were lysed in 20 mM Tris pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM ethylenediaminetetraacetic acid (EDTA), 0.1% SDS, 1:100 protease inhibitor, and 1:200 phosphatase inhibitor. Samples (20 lg of protein) were heated for 5 min at 958C in sample buffer with dithiothreitol and analyzed by SDS-PAGE. Proteins were transferred (25 V, 1.5 h) to polyvinydene difluoride membranes. Nonspecific binding was blocked with Odyssey blocking buffer (1:1 with PBS) for 1 h at room temperature. For detection, we used specific antibodies (rabbit anti-S1PR1 1:100, rabbit anti-S1PR2 1:200, rabbit anti-S1PR3 1:100, rabbit anti-SPHK1 1:100, rabbit anti-SGPP1 1:100, rabbit anti-SGPP2 1:100, rabbit anti-S1P lyase 1:200, rabbit anti-LPP3 1:100, and mouse anti-GAPDH 1:10 000) with overnight incubation at 48C in blocking buffer (1:4 with PBS, containing 0.01% Tween-20). After washing with PBS containing 0.01% Tween-20 (four times, 5 min each), the membranes were incubated with goat anti-rabbit IRDye 680 (1:15 000) or goat anti-mouse IRDye 800CW (1:30 000) in blocking buffer (1:1 with PBS) containing 0.1% Tween-20 and 0.01% SDS for 45 min at room temperature. The membranes were washed (four times, 5 min each) again and scanned with the Odyssey system (LI-COR). The analysis was normalized to GAPDH control. Also, an identical control sample was applied to each gel so that all the results could then be expressed relative to this control.
Measurement of SPHK Activities
Tissues were lysed by freeze-thawing in SPHK buffer as described [21, 22] . Protein concentrations were measured by the bicinchoninic acid method using BSA as a standard. Cell lysates were incubated in 200 ll with 0.5 mM sphingosine in the presence of 15 mM MgCl 2 and 1.5 mM ATP containing 5 lCi of [c- 32 P] ATP for 30 min at 378C to measure total SPHK activity. The activity of SPHK1 was measured in the presence of 0.5% Triton X-100 to abolish SPHK2 activity, and the activity of SPHK2 was measured in the presence of 0.5 M KCl to abolish SPHK1 activity [16] . All the reactions were stopped by adding 20 ll of 1 M HCl, followed by 530 ll of 2 M KCl. Sphingosine 1-phosphate was extracted into 750 ll water-saturated butanol [22] with 10 nmol S1P added as a standard. After centrifuging at 2800 3 g for 10 min, the organic phase was washed once with butanol-saturated water. The butanol phase was evaporated, and the lipids were dissolved in 100 ll chloroform/methanol (95:5, by vol.). Samples of the lipids (50 ll) were resolved by thin layer chromatography on silica gel G using butan-1-ol/ methanol/acetic acid/water (80:20:10:20, by vol.) for development. Sphingosine 1-phosphate was visualized by spraying with ninhydrin, and the identity of the radioactive S1P was confirmed by autoradiography. Bands containing S1P were cut out, and the 32 P was quantified by scintillation counting. 
Phosphatidic Acid Phosphatase Activity Assay
Tissues were prepared in SPHK buffer as previously described above. Three protein concentrations of each sample were assayed in 100 ll, with 100 mM Tris buffer (pH 6.5), 2mg/ml BSA, 6 mM N-ethylmaleimide, 0.6 mM of [ 3 H]palmitate-labeled phosphatidate (0.4 Ci/mol), 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid, and 0.5% Triton X-100 [23] . After a 60-min incubation at 378C, the reactions were stopped with 2.2 ml of chloroform/ methanol (95:5, by vol.), and 1 g basic alumina was added to remove phosphatidate and palmitate [24] . Samples of the chloroform phase (1 ml) were dried, and [ 3 H] diacylglycerol was measured by liquid scintillation counting. This assay using phosphatidate as a substrate was chosen so that PPAP2 activity could be measured in the absence of a contribution from the specific SGPPs.
Statistical Analysis
Results are expressed as the mean 6 SEM for each group. Group analysis was performed using a two-way ANOVA followed by Dunn multiple comparison test using Prism software. No differences were detected in any samples between in labor and not in labor samples. These samples were therefore combined, and statistically significant differences between preterm and term groups were calculated by using an unpaired t-test with Welch correction, which does not assume equal variances. According to the normality of samples, Pearson product-moment correlation coefficient or Spearman rank correlation coefficient was performed to determine if the results were dependent on gestational age. Values with P , 0.05 were considered statistically significant.
RESULTS
SPHK Expression and Activity in Human Decidua
Differential SPHK1 expression in decidual tissues from each group was initially studied by immunofluorescence. Decidual cells were distinguished from trophoblasts by staining for vimentin (decidual cells) or cytokeratin (trophoblasts) (see Supplemental Fig. S1 ). SPHK1 expression appeared to be greater in all the samples isolated from term compared to preterm pregnancies (Fig. 1) .
Real-time PCR and Western blot analysis were used to quantify this apparent gestational-age change in expression. There were no significant differences in SPHK1 mRNA expression as a function of gestational age or between groups (Fig. 2, A and B) . However, the protein expression of SPHK1 correlated significantly with increasing gestational age and was increased in term compared to preterm samples (Fig. 2, C and  D) , confirming the immunofluorescence observations. There was no significant effect of labor on the expression of SPHK1 or any other parameter examined. The labor and not in labor results were therefore combined, and the results from all preterm samples (,37 wk) were compared with results from all term samples.
SPHK activity was measured to establish the physiological relevance of increased SPHK1 immunofluorescence and protein expression at term. Total SPHK activity increased as gestational age increased, and there was a significant increase in samples from term compared to preterm subjects (Fig. 3, A  and B) . Differential assays were used to distinguish between SPHK1 and SPHK2 activities [16] . There was increased SPHK1 activity as a function of gestational age (Fig. 3D) , but the apparent increase in SPHK1 activity in the term compared to preterm samples did not reach statistical significance (Fig.  3C ). There was no significant change in SPHK2 activity throughout gestational age (Fig. 3, E and F) . Our combined results in Figures 2 and 3 indicate that SPHK activity increased as pregnancy progresses, and this was a result of increased expression and activity of SPHK1.
Enzymes of S1P Degradation
The mRNA expression of SGPL1 that irreversibly degrades intracellular S1P correlated positively with increasing gestational age and was also increased in term compared to preterm samples (Fig. 4, A and B) . Although there was no correlation of SGPL1 protein expression with gestational age (Fig. 4D),   FIG. 1 . Visualization of sphingosine kinase-1 expression in human decidua by immunofluorescence. Representative micrographs are shown. Sections containing decidual samples were stained by double immunofluorescence to visualize SPHK1 expression in vimentin-positive cells (decidua). Secondary antibodies to anti-SPHK1 and antivimentin were tagged with Alexa Fluor 488 (green) or Alexa Fluor 594 (red), and DAPI (blue) was used to depict the nuclei. The insets in the right upper corner of each panel depict staining in the absence of SPHK1 primary antibody. PTNIL, preterm not in labor, (n ¼ 2); PTL, preterm in labor, (n ¼ 6); TNIL, term not in labor, (n ¼ 6); TL, term in labor, (n ¼ 6). Original magnification 3400.
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there was an increased expression of SGPL1 protein in term compared to preterm samples (Fig. 4C) .
SGPPs dephosphorylate S1P to sphingosine, which can then be converted to ceramide or reformed into S1P by SPHK activity. Both SGPP1 and SGPP2 were detected in human decidua by real-time PCR. However, only SGPP1 showed increased mRNA expression in term compared to preterm samples (see Supplemental Figs. S2 and S3 ). There were no significant differences in SGPP1 or SGPP2 protein expression.
PPAP2s are ectoenzymes that dephosphorylate extracellular S1P, but they can also exert intracellular effects [12] . Interestingly, PPAP2B mRNA expression increased signifi- cantly with increasing gestational age and also increased in term compared to preterm samples (Fig. 5, A and B) . However, there were no differences in PPAP2B protein expression (Fig.  5, C and D) . PPAP2C showed no significant difference in mRNA expression, but mRNA for PPAP2A was significantly increased with increasing gestational age (see Supplemental  Fig. S4 ). There were no changes in total PPAP2 activity as a function of gestational age or at term compared to preterm samples (Fig. 5, E and F) .
S1P Receptor Expression
Extracellular S1P signals through S1P receptors. The expressions of all five S1P receptors were, therefore, investigated in human decidua throughout gestation. We did not detect mRNA for S1PR4 or S1PR5 by real-time PCR. Although mRNA for S1PR1 and S1PR2 were detected, there were no significant changes as a function of gestational age, and S1PR1 protein expression also did not change (see Supplemental Figs. S5 and S6 ). We were unable to evaluate S1PR2 protein expression because of a lack of specific antibodies. Although there was no significant change in S1PR3 mRNA, S1PR3 protein expression increased with gestational age and in term compared to preterm samples (Fig. 6, A-D) .
DISCUSSION
In this study, we show for the first time the expression of SPHK1, SGPL1, PPAP2A-C, SGPP1 and 2, S1PR1-3, but not S1PR4 or 5 in human decidua. Our major finding is that SPHK activity in human decidua correlates positively with increasing gestational age and is increased in term compared to preterm samples. This increased activity is caused by changes in SPHK1 rather than SPHK2. SGPL1 mRNA and protein also increase in term compared to preterm samples. These two opposing results suggest increased S1P turnover (production and irreversible degradation) in decidua at term. Metabolism of S1P through reversible dephosphorylation is unlikely to change with increasing gestation since total PPAP2A-C activity and SGPP1 and 2 protein expression did not differ significantly throughout pregnancy. Of the three S1P receptors present in human decidua, only S1PR3 protein levels increased with gestational age and at term. These results suggest that the increased capacity to synthesize S1P could be linked to increased extracellular signaling through S1PR3 in human decidua with advancing gestation.
Both SPHK1 and SPHK2 contribute to overall S1P production as shown by Sphk1 knockout mice in which there is a significant loss of SPHK activity, but in which S1P levels are only reduced in serum and not in tissues [25] . The expression of SPHK isoforms depends on tissue type, as SPHK1 is the highest in lung, spleen, kidney, and blood whereas SPHK2 is predominantly found in liver, kidney, brain, and heart [26] . Inactive SPHK1 is found in the cytosol, and upon stimulation by factors such as cytokines, it is phosphorylated and translocated to the plasma membrane or the perinuclear region where it is active [27, 28] . Regulation of SPHK activity in pregnancy has been suggested in the rat model where both SPHK1 and SPHK2 are activated at the end of pregnancy in myometrium probably through the actions of prostaglandin-endoperoxide synthase 2 (PTGS2) and cytokines [16] . Indeed, Jeng et al. showed that Sphk1 mRNA, but not Sphk2 mRNA, increased 30-fold on gestation Day 15 in the rat uterus (term ¼ Day 19.5) [14] . In contrast, although SPHK1 mRNA was not changed in our study of human pregnancy, the increase in SPHK1 protein expression and SPHK activity levels suggests regulation at the level of translation as pregnancy progresses. Moreover, we observed increased SPHK1 staining intensity in term compared to preterm decidua.
Sphingosine 1-phosphate levels are also regulated by degradation and dephosphorylation. SGPL1, which leads to the irreversible degradation of S1P, was increased in term compared to preterm samples for both mRNA and protein.
However, only the mRNA for SGPL1 significantly correlated SPHINGOSINE 1-PHOSPHATE IN HUMAN DECIDUA with increasing gestational age, suggesting translational regulation before term. If SGPL1 levels are low before term and at the same time, there is increased SPHK activity, this could result in increased intracellular and released S1P levels. At term the increased SGPL1 protein expression along with increased SPHK activity suggests increased turnover of S1P. However, it is important to remember that all measurements were done on tissues frozen at a single point in time and without the benefit of monitoring a response over time. These interpretations would therefore have to be further investigated.
Reversible dephosphorylation of intracellular S1P is accomplished by two specific SGPPs and the nonspecific PPAP2s. Intracellular S1P plays important roles inside the cell, including antiapoptosis and calcium regulation, and the extent of this is in part regulated by intracellular dephosphorylation of S1P. We found no significant change in protein expression of the two SGPPs although there was a significant increase in mRNA expression of SGPP1 in term compared to preterm samples. Both intracellular and extracellular S1P are also regulated by the ectoactivities of PPAP2s that dephosphorylate extracellular S1P. The resulting sphingosine is taken up by cells to be reconverted to S1P by SPHK1 [29] , or it can be metabolized to ceramide [12] . This is of particular interest in determining the net release of S1P by the decidua. Secreted S1P can signal in an autocrine or paracrine manner within the decidua, or to other tissues including the myometrium. Leiber et al. showed that exogenous S1P induced myometrial contraction [19] . We, however, found no significant change in overall PPAP2 activity with increasing gestational age or at term compared to preterm. The lack of change in PPAP2s, SGPPs, or SGPL1 along with the increase in SPHK1 activity before term could result in S1P accumulation inside the cell and its increased release by human decidua before term.
These extracellular signals depend on the types of S1P receptors expressed on various cells. We and others previously reported S1PR expression in human placental, myometrial, and omental arteries [30, 31] and also in primary human cytotrophoblasts [32] . We now find that S1PR1-S1PR3, but not S1PR4 or S1PR5, are expressed in human decidua. We detected a significant correlation in the expression of S1PR3, but not S1PR1 or S1PR2, in decidua with advancing gestational age. The role of increased signaling by S1P through S1PR3 in decidua itself is not known, but we predict its importance in production of cytokines important to the induction of labor. Interestingly, in a rat model, mRNA for S1pr1 was elevated at the end of pregnancy in whole uterine tissue, whereas the S1pr3 mRNA levels were reduced by almost 50% on gestational days 15, 17, and 19 compared with the nonpregnant uterus. S1pr2 mRNA expression was relatively constant during pregnancy [16] . Skaznik-Wikiel et al. reported that S1PR3 is increased in decidua of mice in early pregnancy (Days 4.5 to 9.5), but also reported increases in S1PR1 and S1PR2, which we did not observe at the end of pregnancy in human decidua [33] . The regulation of S1P receptors in decidua is not understood, but it is possible that the mechanism of S1PR3 upregulation might be coupled to that for SPHK1 and involve increased translation since no changes were observed in mRNA expression.
Overall, our results suggest that production of S1P in human decidua increases until term as shown by increased SPHK1 protein expression and activity along with a lack of change in either the phosphatases or the SGPL1 protein expression before term. At term, SPHK1 expression is likely balanced by the increased production of SGPL1, leading to increased turnover of S1P at term. The increased S1PR3 protein expression as a function of gestational age implicates increased S1P signaling preterm. No change was detected in S1PR1 or S1PR2 as gestation increased; however, signaling through these receptors could also be increased as a result of the increased S1P levels. Because these events were not affected by the onset of labor, this probably means that S1P affects decidual maturation that terminates in labor events and that S1P-regulating enzymes are not affected by the consequences of labor. At this time, we can only suggest what these S1P effects might be. One effect could be to prepare the decidua to increase cytokine production. Leukocytes accumulate in decidua in late pregnancy, and decidua produces more cytokines than chorion or amnion [34] , including the key cytokines IL1B and IL8, which facilitate uterine contraction [35] . Release of S1P by cells promotes leukocyte attraction [36] , and this could contribute to the leukocyte infiltration. Further, S1P produced by the decidua may be involved in cytokine-mediated stimulation of decidual prostaglandin production. For instance, S1P is necessary for TNF-a to induce PTGS2 and prostaglandin E2 production [4] . Skaznik-Wikiel et al. showed that treatment of cultured predecidualized mouse stromal cells with S1P increased Ptgs2 mRNA and protein in early pregnancy [33] . A recent study by Serrano-Sanchez et al. demonstrated the IL1B-mediated activation of PTGS2 seemed to involve protein kinase C, extracellular signal-regulated kinase, and SPHK1 activation in rat myometrium [16] . Hence, the SPHK1 increase in late gestation could induce several events that lead to decidual maturation for parturition.
In addition to the possibility that proinflammatory cytokines drive SPHK1 activity and increase S1P levels, Jeng et al. showed that uterine SPHK1 levels in pregnant rats parallels serum progesterone concentrations [14] . The peak of SPHK1 expression coincides with the peak of serum progesterone concentrations prior to luteolysis and the fall in circulating progesterone [37, 38] . In addition, SPHK1 expression in the uterus of nonpregnant rats was increased after treatment with progesterone, which was reversed by cotreatment with a progesterone receptor antagonist [14] . SPHK activity was also induced in a dose-dependent manner by 17b-estradiol in MCF-7 breast cancer cells [3] . Therefore, the increase in circulating estrogen in the third trimester of pregnancy could also be involved in the increased expression of SPHK1 if the decidua were to respond in a similar manner.
In conclusion, our results demonstrate for the first time that there is an increase in SPHK1 protein expression and activity as well as SGPL1 and S1PR3 protein expression in human decidua in late gestation. This study lays the foundation for further work on the role of S1P in decidua during quiescence and also in decidual maturation during pregnancy.
